array:19 [
  "pii" => "X0211699504029449"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2004-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2004;24 Supl 1:74"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2309
    "formatos" => array:3 [
      "EPUB" => 237
      "HTML" => 1616
      "PDF" => 456
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699504029430"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2004-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2004;24 Supl 1:75-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3142
      "formatos" => array:3 [
        "EPUB" => 240
        "HTML" => 2245
        "PDF" => 657
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Detección precoz de la nefropatía en la diabetes tipo 2"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "75"
          "paginaFinal" => "76"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "R. MARÍN"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "R. MARÍN"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029430?idApp=UINPBA000064"
    "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029430/v0_201502091335/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699504029457"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2004-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2004;24 Supl 1:73"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4236
      "formatos" => array:3 [
        "EPUB" => 261
        "HTML" => 3252
        "PDF" => 723
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Marcadores inflamatorios y enfermedad cardiovascular. Efecto del tratamiento hipolipemiante"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "73"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "V. CACHOFEIRO , V. LAHERA , P. LOPEZ JARAMILLO"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "V. CACHOFEIRO , V. LAHERA , P. LOPEZ JARAMILLO"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029457?idApp=UINPBA000064"
    "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029457/v0_201502091335/es/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "Microalbuminuria, una clave para las complicaciones diabéticas y su tratamiento"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "74"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "C. E. MOGENSEN"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "C. E. MOGENSEN"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XXIV. Número Extraordinario (I). 2004 Microalbuminuria, una clave para las complicaciones diabéticas y su tratamiento C. E. Mogensen Aarhus Kommune Hospital. Aarhus. Denmark. BACKGROUND Over the past 20 years, there has been a remarkable increase in the number of patients with diabetes entering end-stage renal failure programmes with the need for dialysis. This can partly be explained by the increasing number of people with type 2 diabetes due to the «diabetes epidemic», but also due to the fact that many patients survive longer these days. Several reviewers indicate that blood pressure is not effectively controlled in diabetic patients. THE CONCEPT OF MICROALBUMINURIA AS AN INITIAL STAGE OF DIABETIC RENAL DISEASE Microalbuminuria is now widely accepted as the first laboratory sign of renal disease in diabetes, both type 1 and type 2. Obviously, in type 2 there may be competing reasons for the appearance of microalbuminuria, e.g. elevated blood pressure, which is quite common in patients with type 2 diabetes. It has been confirmed in many studies, latest in the UKPDS, that microalbuminuria predicts worsening of renal disease and also early mortality. Microalbuminuria is associated with all cardiovascular complications, including retinopathy. OVERT NEPHROPATHY, INCREASING BLOOD PRESSURE Overt nephropathy is characterised by proteinuria with subsequent rapid decline in GFR if diabetes and hypertension is not well controlled. When patients are about to enter the stage of proteinuria, GFR is usually rather well-preserved so therefore it is important to find patients early on to protect them against a decline in renal function, by screening for microalbuminuria. THE RENIN ANGIOTENSIN SYSTEM IN DIABETES The concept of blocking the renin angiotensin system in diabetes is a key concept in the management of patients. In all stages of diabetic renal involvement, blocking the renin angiotensin system reduces the rate of progression. New studies in type 2 diabetes document that using angiotensin receptor blockers (ARBs) significantly reduce the risk of end-stage renal failure with patients with type 2 diabetes. Many studies show that intervention in the stage of microalbuminuria is very efficient in reducing albuminuria and probably preserving renal function. When proteinuria is documented, the rate of decline in GFR may be reduced, but not completely normalised, and unfortunately, these patients will still have a poor prognosis, even with treatment. Therefore, it is important to screen patients for microalbuminuria and treat them early on. New studies document that so-called dual blockade is efficacious in reducing blood pressure and slowing the progression of renal involvement, not only in diabetes, but also in non-diabetic renal involvement. CONCLUSION The key issue is to obtain the best possible glycemic control in diabetes and to normalize blood pressure, usually by blocking the renin angiotensin system, often in combination with diuretics and other antihypertensive agents. Screening for microalbuminuria is essential in identifying at risk patients. In this way, the clinical course of complications can be considerably ameliorated and the need to renal and cordial supportive treatment may be postponed considerably. A general goal may be a BP below 130-120/7080 mmHg --the lower, the better. 74 "
    "pdfFichero" => "P7-E232-S132-A3001.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029449/v0_201502091335/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35393"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Artículos Originales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000024000000S1/v0_201502091335/X0211699504029449/v0_201502091335/en/P7-E232-S132-A3001.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029449?idApp=UINPBA000064"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

Microalbuminuria, una clave para las complicaciones diabéticas y su tratamiento
C. E. MOGENSEN
Leído
6001
Veces
se ha leído el artículo
1979
Total PDF
4022
Total HTML
Compartir estadísticas
 array:19 [
  "pii" => "X0211699504029449"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2004-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2004;24 Supl 1:74"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2309
    "formatos" => array:3 [
      "EPUB" => 237
      "HTML" => 1616
      "PDF" => 456
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699504029430"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2004-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2004;24 Supl 1:75-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3142
      "formatos" => array:3 [
        "EPUB" => 240
        "HTML" => 2245
        "PDF" => 657
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Detección precoz de la nefropatía en la diabetes tipo 2"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "75"
          "paginaFinal" => "76"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "R. MARÍN"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "R. MARÍN"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029430?idApp=UINPBA000064"
    "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029430/v0_201502091335/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699504029457"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2004-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2004;24 Supl 1:73"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4236
      "formatos" => array:3 [
        "EPUB" => 261
        "HTML" => 3252
        "PDF" => 723
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Marcadores inflamatorios y enfermedad cardiovascular. Efecto del tratamiento hipolipemiante"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "73"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "V. CACHOFEIRO , V. LAHERA , P. LOPEZ JARAMILLO"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "V. CACHOFEIRO , V. LAHERA , P. LOPEZ JARAMILLO"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029457?idApp=UINPBA000064"
    "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029457/v0_201502091335/es/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "Microalbuminuria, una clave para las complicaciones diabéticas y su tratamiento"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "74"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "C. E. MOGENSEN"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "C. E. MOGENSEN"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XXIV. Número Extraordinario (I). 2004 Microalbuminuria, una clave para las complicaciones diabéticas y su tratamiento C. E. Mogensen Aarhus Kommune Hospital. Aarhus. Denmark. BACKGROUND Over the past 20 years, there has been a remarkable increase in the number of patients with diabetes entering end-stage renal failure programmes with the need for dialysis. This can partly be explained by the increasing number of people with type 2 diabetes due to the «diabetes epidemic», but also due to the fact that many patients survive longer these days. Several reviewers indicate that blood pressure is not effectively controlled in diabetic patients. THE CONCEPT OF MICROALBUMINURIA AS AN INITIAL STAGE OF DIABETIC RENAL DISEASE Microalbuminuria is now widely accepted as the first laboratory sign of renal disease in diabetes, both type 1 and type 2. Obviously, in type 2 there may be competing reasons for the appearance of microalbuminuria, e.g. elevated blood pressure, which is quite common in patients with type 2 diabetes. It has been confirmed in many studies, latest in the UKPDS, that microalbuminuria predicts worsening of renal disease and also early mortality. Microalbuminuria is associated with all cardiovascular complications, including retinopathy. OVERT NEPHROPATHY, INCREASING BLOOD PRESSURE Overt nephropathy is characterised by proteinuria with subsequent rapid decline in GFR if diabetes and hypertension is not well controlled. When patients are about to enter the stage of proteinuria, GFR is usually rather well-preserved so therefore it is important to find patients early on to protect them against a decline in renal function, by screening for microalbuminuria. THE RENIN ANGIOTENSIN SYSTEM IN DIABETES The concept of blocking the renin angiotensin system in diabetes is a key concept in the management of patients. In all stages of diabetic renal involvement, blocking the renin angiotensin system reduces the rate of progression. New studies in type 2 diabetes document that using angiotensin receptor blockers (ARBs) significantly reduce the risk of end-stage renal failure with patients with type 2 diabetes. Many studies show that intervention in the stage of microalbuminuria is very efficient in reducing albuminuria and probably preserving renal function. When proteinuria is documented, the rate of decline in GFR may be reduced, but not completely normalised, and unfortunately, these patients will still have a poor prognosis, even with treatment. Therefore, it is important to screen patients for microalbuminuria and treat them early on. New studies document that so-called dual blockade is efficacious in reducing blood pressure and slowing the progression of renal involvement, not only in diabetes, but also in non-diabetic renal involvement. CONCLUSION The key issue is to obtain the best possible glycemic control in diabetes and to normalize blood pressure, usually by blocking the renin angiotensin system, often in combination with diuretics and other antihypertensive agents. Screening for microalbuminuria is essential in identifying at risk patients. In this way, the clinical course of complications can be considerably ameliorated and the need to renal and cordial supportive treatment may be postponed considerably. A general goal may be a BP below 130-120/7080 mmHg --the lower, the better. 74 "
    "pdfFichero" => "P7-E232-S132-A3001.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029449/v0_201502091335/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35393"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Artículos Originales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000024000000S1/v0_201502091335/X0211699504029449/v0_201502091335/en/P7-E232-S132-A3001.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029449?idApp=UINPBA000064"
]
Información del artículo
ISSN: 02116995
Idioma original: Inglés
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 5 10 15
2024 Octubre 45 43 88
2024 Septiembre 58 33 91
2024 Agosto 63 61 124
2024 Julio 52 33 85
2024 Junio 66 36 102
2024 Mayo 60 31 91
2024 Abril 65 33 98
2024 Marzo 34 21 55
2024 Febrero 46 46 92
2024 Enero 70 21 91
2023 Diciembre 28 22 50
2023 Noviembre 86 28 114
2023 Octubre 53 33 86
2023 Septiembre 85 22 107
2023 Agosto 101 24 125
2023 Julio 97 27 124
2023 Junio 97 18 115
2023 Mayo 89 32 121
2023 Abril 36 18 54
2023 Marzo 39 18 57
2023 Febrero 24 24 48
2023 Enero 32 25 57
2022 Diciembre 40 40 80
2022 Noviembre 36 18 54
2022 Octubre 32 47 79
2022 Septiembre 38 25 63
2022 Agosto 40 44 84
2022 Julio 33 39 72
2022 Junio 37 40 77
2022 Mayo 33 30 63
2022 Abril 44 41 85
2022 Marzo 49 35 84
2022 Febrero 29 36 65
2022 Enero 32 25 57
2021 Diciembre 35 40 75
2021 Noviembre 25 25 50
2021 Octubre 38 45 83
2021 Septiembre 38 32 70
2021 Agosto 19 26 45
2021 Julio 42 30 72
2021 Junio 23 17 40
2021 Mayo 22 31 53
2021 Abril 55 15 70
2021 Marzo 34 23 57
2021 Febrero 25 18 43
2021 Enero 24 15 39
2020 Diciembre 11 11 22
2020 Noviembre 23 8 31
2020 Octubre 23 11 34
2020 Septiembre 18 3 21
2020 Agosto 33 9 42
2020 Julio 22 16 38
2020 Junio 19 17 36
2020 Mayo 37 18 55
2020 Abril 23 16 39
2020 Marzo 25 10 35
2020 Febrero 30 15 45
2020 Enero 41 21 62
2019 Diciembre 33 21 54
2019 Noviembre 31 11 42
2019 Octubre 14 11 25
2019 Septiembre 21 17 38
2019 Agosto 11 15 26
2019 Julio 27 26 53
2019 Junio 17 10 27
2019 Mayo 16 24 40
2019 Abril 50 36 86
2019 Marzo 12 18 30
2019 Febrero 10 11 21
2019 Enero 11 14 25
2018 Diciembre 35 23 58
2018 Noviembre 35 11 46
2018 Octubre 36 17 53
2018 Septiembre 30 7 37
2018 Agosto 21 11 32
2018 Julio 28 12 40
2018 Junio 13 6 19
2018 Mayo 25 17 42
2018 Abril 17 7 24
2018 Marzo 21 9 30
2018 Febrero 19 3 22
2018 Enero 12 9 21
2017 Diciembre 21 7 28
2017 Noviembre 17 5 22
2017 Octubre 20 5 25
2017 Septiembre 11 8 19
2017 Agosto 16 7 23
2017 Julio 13 8 21
2017 Junio 11 3 14
2017 Mayo 22 5 27
2017 Abril 12 7 19
2017 Marzo 10 5 15
2017 Febrero 16 4 20
2017 Enero 8 4 12
2016 Diciembre 16 5 21
2016 Noviembre 12 4 16
2016 Octubre 36 2 38
2016 Septiembre 55 2 57
2016 Agosto 42 1 43
2016 Julio 75 0 75
2016 Junio 68 0 68
2016 Mayo 80 0 80
2016 Abril 36 0 36
2016 Marzo 33 0 33
2016 Febrero 52 0 52
2016 Enero 42 0 42
2015 Diciembre 55 0 55
2015 Noviembre 47 0 47
2015 Octubre 31 0 31
2015 Septiembre 36 0 36
2015 Agosto 45 0 45
2015 Julio 33 0 33
2015 Junio 17 0 17
2015 Mayo 23 0 23
2015 Abril 7 0 7
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?